STUDY ON CORRELATION OF P2Y12 GENE POLYMORPHISMS IN RS9848789 AND RS2046934 SITES WITH CORONARY HEART DISEASE

被引：0
|
作者：
Zhangxinxia, Chenxiaoyan [1 ]
Zhangwenbin, Moyihao [1 ]
Baoshimin, Wujiansheng [1 ]
Huxuesong, Zhangxinxia [1 ]
机构：
[1] Guangdong Med Coll, Shenzhen Futian Hosp, Shenzhen, Peoples R China
来源：
HEART | 2012年 / 98卷
关键词：
D O I：
10.1136/heartjnl-2012-302920a.276
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E104 / E104
页数：1
相关论文
共 50 条
  • [31] Association of the L3MBTL3 rs1125970 and rs4897367 Gene Polymorphisms With Coronary Heart Disease Susceptibility in the Chinese Population: A Case-Control Study
    Li, Yongdong
    Zhang, Jiaqiang
    He, Jun
    Chen, Xiaoyu
    Zhang, Xianbo
    Wu, Haiqing
    Ding, Yipeng
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2023, 82 (05) : 350 - 363
  • [32] SCARB1 rs5888 gene polymorphisms in coronary heart disease: A systematic review and a meta-analysis
    Ma, Ruchao
    Zhu, Xiaoyun
    Yan, Bo
    GENE, 2018, 678 : 280 - 287
  • [33] Meta-Analysis of the Association of the Rs2234693 and Rs9340799 Polymorphisms of Estrogen Receptor Alpha Gene with Coronary Heart Disease Risk in Chinese Han Population
    Wei, Chuan-Dong
    Zheng, Hong-Yun
    Wu, Wei
    Dai, Wen
    Tong, Yong-Qing
    Wang, Ming
    Li, Yan
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (04): : 457 - 466
  • [34] Benefits and Harm of Treatment with P2Y12 Inhibitors beyond 12 Months in Patients with Coronary Artery Disease
    Larsen, Mads Lamm
    Grove, Erik Lerkevang
    Kristensen, Steen Dalby
    Hvas, Anne-Mette
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2020, 46 (04): : 446 - 456
  • [35] Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease
    Angiolillo, DJ
    Fernandez-Ortiz, A
    Bernardo, E
    Ramírez, C
    Cavallari, U
    Trabetti, E
    Sabaté, M
    Jimenez-Quevedo, P
    Hernández, R
    Moreno, R
    Escaned, J
    Alfonso, F
    Bañuelos, C
    Costa, MA
    Bass, TA
    Pignatti, PF
    Macaya, C
    THROMBOSIS RESEARCH, 2005, 116 (06) : 491 - 497
  • [36] Association study of dimethylarginine dimethylaminohydrolase 2 gene polymorphisms and coronary heart disease
    Xu, Ai-Guo
    Xu, Rong-Mei
    Lu, Chang-Qing
    Li, Dan-Dan
    Xu, Qin-Fu
    Guo, Jing
    Fu, Xin
    Zhao, Wei
    Yao, Meng-Ying
    MOLECULAR MEDICINE REPORTS, 2012, 6 (05) : 1103 - 1106
  • [37] NOS3 RS1799983 AND RS2070744 POLYMORPHISMS AND THEIR ASSOCIATION WITH ADVANCED CHRONIC KIDNEY DISEASE AND CORONARY HEART DISEASE IN CANARIAN POPULATION WITH TYPE 2 DIABETES
    Boronat, M.
    Tugores, A.
    Saavedra, P.
    Garay, P.
    Bosch, E.
    Lorenzo, D.
    Ibarra, A.
    Garcia-Canton, C.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2021, 17 (04) : 440 - 448
  • [38] COMPARATIVE EFFECTS OF DIFFERENT P2Y12 INHIBITORS ON GLOBAL THROMBOTIC STATUS IN CORONARY ARTERY DISEASE
    Spinthakis, Nikolaos
    Farag, Mohamed
    Srinivasan, Manivannan
    Wellsted, David
    Gorog, Diana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 264 - 264
  • [39] P2Y12 Inhibitor or Aspirin Monotherapy in Patients with Coronary Artery Disease: is it Time for a Paradigm Shift?
    Gragnano, Felice
    Capolongo, Antonio
    Calabro, Paolo
    CURRENT VASCULAR PHARMACOLOGY, 2024, 22 (01) : 1 - 4
  • [40] Association between platelet P2Y12 haplotype and risk of cardiovascular events in chronic coronary disease
    Schettert, Isolmar T.
    Pereira, Alexandre C.
    Lopes, Neuza H.
    Hueb, Whady A.
    Krieger, Jose E.
    THROMBOSIS RESEARCH, 2006, 118 (06) : 679 - 683
12345